Synthego co-founder Paul Dabrowski is coming to Disrupt New York 2017

 Genetic engineering startup Synthego makes synthetic ribonucleic acid (RNA), an important genetic component found in all living cells and also used in CRISPR Cas9, a technology enabling scientists to rip out unwanted genetic code with scissor-like precision.
The company was founded four years ago by brothers Paul and Michael Dabrowski. The two left SpaceX where they both worked as rocket… Read More

Powered by WPeMatico

Oscar Health rolls out its small business product Oscar for Business

 Oscar Health, a startup rethinking health insurance for the digital age, is rolling out a new product for small businesses called Oscar for Business. The rollout comes as Oscar struggles with its original bet on individual insurance through the Affordable Care Act, a move which vaulted the company, now valued at $2.7 billion, to initial success. Oscar was the only startup that had the approval… Read More

Powered by WPeMatico

Theranos says it has been mischaracterized in allegations the company faked tests

 Theranos secretly bought lab equipment through a shell company, faked tests and inappropriately pumped up its financial outlook to investors, according to allegations in recently unsealed court documents, first reported by the Wall Street Journal. Partner Fund Management LP, a hedge fund management firm which invested $96 million in Theranos filed the claim in Delaware Chancery Court on… Read More

Powered by WPeMatico

Form an orderly queue! Google wants your blood (and other bodily fluids). Oh and your medical records

 Alphabet’s (Google’s) life sciences division Verily has launched its public pitch for a massive, multi-year health study it’s leading, along with Duke University School of Medicine, Stanford Medicine, and Google proper. Read More

Powered by WPeMatico

Elon Musk’s Neuralink wants to turn cloud-based AI into an extension of our brains

 Elon Musk has been working on a Neuralink, a human-computer brain interface company, in whatever spare moments he has between running Tesla and also running SpaceX. Neuralink’s ultimate aim may actually be the most ambitious of all three of his companies, surprisingly, and a new exploration of the foundational ideas behind Neuralink on Wait But Why goes deep within what Musk hopes to… Read More

Powered by WPeMatico

ZappRX gets $25 million from Chinese VC’s to expand into the U.S. drug prescription market

 ZappRX, the app that aims to make it easier to manage specialty drug prescriptions, has pulled in $25 million in Series B funding led by Qiming US, the Chinese venture outfit’s stateside health care fund. GV (formerly Google Ventures) and GlaxoSmithKline’s funding arm SR One were also in the round and GV’s Krishna Yeshwant and Qiming US’s Mark McDade will now join… Read More

Powered by WPeMatico